Answers are grounded in this paper and cite their sources.
Targeted protein degradation has shown powerful capability for diseases treatment. However, the approach is limited by the challenges in cellular internalization of synthetic degrader and potential cytotoxicity. Herein, we propose a Genetically encoded circular RNA Aptamer-based DEgrader (GRADE) to control target proteins degradation. The GRADE system is facilely constructed by integrating a transferrin receptor (TfR1) aptamer and target protein aptamer for delivering target protein into damaged endosomes and TfR1 binding, leading to target protein degradation via endosomal autophagy pathways. We show that the versatile and modular GRADE could be applied to eliminate several intracellular target proteins. Moreover, the GRADE system can be selectively activated by endogenous biomarkers for achieving highly specific protein degradation and cancer cell precise inhibition. This study presents a non-invasive, effective and general platform for intracellular protein degradation, offering new insights into controlled cell manipulation and diseases therapy.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: